Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07207694) titled 'WhatsApp-Based Education Program for Stroke Patients' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Condition:
Type 2 Diabetes Mellitus (T2DM)
Stroke
Intervention:
Behavioral: WhatsApp-based education group
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 15, 2025
Target Sample Size: 84
To know more, visit https://clinicaltrials.gov/study/NCT07207694
Publi...